Derek M Davis Form 3/A ZIMMER BIOMET / Derek M Davis ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Davis Derek M

(Last) (First) (Middle)

345 E. MAIN STREET

(Street)

WARSAW IN 46580

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
11/26/2021

3. Issuer Name and Ticker or Trading Symbol
ZIMMER BIOMET HOLDINGS, INC. [ ZBH ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Interim Controller & CAO

5. If Amendment, Date of Original Filed (Month/Day/Year)
12/06/2021

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	915.997	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	(1)	06/24/2025	Common Stock	9,445	113.83	D
Employee Stock Option (right to buy)	(1)	03/21/2026	Common Stock	10,680	104.01	D
Employee Stock Option (right to buy)	(1)	03/21/2027	Common Stock	8,725	121.88	D
Employee Stock Option (right to buy)	(1)	02/20/2028	Common Stock	9,805	119.61	D
Employee Stock Option (right to buy)	(2)	03/20/2028	Common Stock	8,335	114.44	D
Employee Stock Option (right to buy)	(3)	02/26/2029	Common Stock	6,533	123.73	D
Employee Stock Option (right to buy)	(4)	02/21/2030	Common Stock	7,133	157.54	D
Employee Stock Option (right to buy)	(5)	02/25/2031	Common Stock	5,088	163.79	D

Explanation of Responses:

1. Fully vested.

2. 6,252 options are vested; the remaining 2,083 options vest on March 20, 2022.

3. 3,267 options are vested; the remaining 3,266 options vest as follows: 1,633 options vest on February 26, 2022 and 1,633 options vest on February 26, 2023.

4. 1,784 options are vested; the remaining 5,349 options vest as follows: 1,783 options vest on February 21, 2022, 1,783 options vest on February 21, 2023 and 1,783 options vest on February 21, 2024.

5. Options vest annually over four years in increments of 25% each year, commencing on February 25, 2022.

Remarks:

This amendment is being filed solely to attach the correct Power of Attorney. Exhibit 24 - Power of Attorney

	Heather Kidwell, Attorney-in-Fact for Derek M. Davis	12/06/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.